BACKGROUND: Autoimmune polyglandular syndrome type 1 (APS 1) is an autosomal recessive disorder characterized by immune injury of multiple organ systems (primarily endocrine) secondary to a mutation in the autoimmune regulator (AIRE) gene. In some cases, patients develop tubulointerstitial nephritis (TIN) and progress to end-stage renal failure (ESRD). CASE DIAGNOSIS/TREATMENT: We describe two patients with APS 1 and TIN. In both cases, TIN was clinically silent and the diagnosis was confirmed by renal biopsy. In one patient, renal function remained stable with immunosuppressive therapy. A second patient progressed to ESRD despite treatment, and received a deceased donor allograft. TIN recurred in the transplanted kidney and was reversed successfully with rituximab. Severe, recurrent esophageal candidiasis also resolved. CONCLUSION: TIN is an important complication of APS 1 that may result in ESRD, and may recur in the transplanted kidney. TIN may be under-recognized, as the presentation is unapparent clinically and urinalysis remains normal. Immunosuppressive therapy may be effective and, therefore, routine monitoring of renal function is warranted in asymptomatic individuals.
BACKGROUND:Autoimmune polyglandular syndrome type 1 (APS 1) is an autosomal recessive disorder characterized by immune injury of multiple organ systems (primarily endocrine) secondary to a mutation in the autoimmune regulator (AIRE) gene. In some cases, patients develop tubulointerstitial nephritis (TIN) and progress to end-stage renal failure (ESRD). CASE DIAGNOSIS/TREATMENT: We describe two patients with APS 1 and TIN. In both cases, TIN was clinically silent and the diagnosis was confirmed by renal biopsy. In one patient, renal function remained stable with immunosuppressive therapy. A second patient progressed to ESRD despite treatment, and received a deceased donor allograft. TIN recurred in the transplanted kidney and was reversed successfully with rituximab. Severe, recurrent esophageal candidiasis also resolved. CONCLUSION: TIN is an important complication of APS 1 that may result in ESRD, and may recur in the transplanted kidney. TIN may be under-recognized, as the presentation is unapparent clinically and urinalysis remains normal. Immunosuppressive therapy may be effective and, therefore, routine monitoring of renal function is warranted in asymptomatic individuals.
Authors: Saila Laakso; Henna Kaijansinkko; Anne Räisänen-Sokolowski; Timo Jahnukainen; Janne Kataja; Outi Mäkitie; Ilkka Helanterä; Hannu Jalanko Journal: Transplantation Date: 2022-04-01 Impact factor: 4.939
Authors: Sarah Wente-Schulz; Marina Aksenova; Atif Awan; Cahyani Gita Ambarsari; Francesca Becherucci; Francesco Emma; Marc Fila; Telma Francisco; Ibrahim Gokce; Bora Gülhan; Matthias Hansen; Timo Jahnukainen; Mahmoud Kallash; Konstantinos Kamperis; Sherene Mason; Antonio Mastrangelo; Francesca Mencarelli; Bogna Niwinska-Faryna; Michael Riordan; Rina R Rus; Seha Saygili; Erkin Serdaroglu; Sevgin Taner; Rezan Topaloglu; Enrico Vidal; Robert Woroniecki; Sibel Yel; Jakub Zieg; Lars Pape Journal: BMJ Open Date: 2021-05-28 Impact factor: 2.692